psalexa
SearchBar Icon

Global Female Fertility and Pregnancy Rapid Test Market to Witness 4.5% CAGR during 2016 – 2022

x
Published Date:   April 2016

The global female fertility and pregnancy rapid test market is predicted to progress at a CAGR of 4.5% during the forecast period. Increasing pool of female aging population, rising incidence of uterine malformations cases, surging number of infertility cases, and increasing adoption of at-home diagnostic test devices are some major factors for the growth of the market. Other than these factors, rising awareness about fertility and pregnancy among females is also likely to increase the demand for female fertility and pregnancy rapid test kits.

The aging female population is increasing across the globe. These females are more prone to a range of hormonal disorders, such as abnormal uterine bleeding, fibroids, and polyps, which require the adoption of fertility and pregnancy rapid test products. Also, the aging females often have the problem of irregular menstruation cycle. Due to these, the female fertility and pregnancy rapid test market is expected to undergo immense growth in the forthcoming years.

Further, the number of infertility cases is increasing across the globe, due to various factors such as alcohol consumption, hormonal imbalance, and unhealthy lifestyle. As reported by the American Pregnancy Association (APA), infertility affects approximately 10–15% across the U.S., with 25% of the overall infertility cases are associated with ovulation problems in females.

Besides, as the age increases, it is difficult for females to conceive that also leads to a large number of infertility cases. With the increasing number of infertility cases, the adoption of fertility rapid test products that can be easily used at-home is likely to increase in the coming years. Also, home-based pregnancy test strips are convenient to use and also maintains the privacy of females, which is expected to continue creating high demand for these products in the female fertility and pregnancy rapid test market in the coming years.

However, factors such as high cost and availability of alternative diagnostic methods will likely to limit the growth of the female fertility and pregnancy rapid test market. Also, midstream products available in the market are costly, compared to strips/dipsticks and cassettes/cards. Hence, patients mainly opt for the latter. This may hamper the demand for the midstream products.

Explore Full Report on “Female fertility and pregnancy rapid test Market” at: https://www.psmarketresearch.com/market-analysis/fertility-and-pregnancy-rapid-test-market

Key companies operating in the global female fertility and pregnancy rapid test market are Alere Inc., Atlas Medical, Diagnostic Automation/Cortez Diagnostics Inc., BioMerieux SA, SA Scientific, Church & Dwight Co. Inc., Nantong Egens Biotechnology Co. Ltd., and Gemc Technology Group Co. Ltd.

FEMALE FERTILITY AND PREGNANCY RAPID TEST MARKET SEGMENTATION

Market Segmentation by Type of Test

  • Luteinizing Hormone (LH)
  • Follicle Stimulating Hormone (FSH)
  • Human Chorionic Gonadotropin (HCG)

Market Segmentation by Product

  • Strips/Dipsticks
    • LH
    • FSH
    • HCG
  • Cards/Cassettes
    • LH
    • FSH
    • HCG
  • Midstreams
    • LH
    • FSH
    • HCG

Market Segmentation by Geography

  • North America Female Fertility and Pregnancy Rapid Test Market
    • By type of test
    • By product
    • By country – U.S, Canada, and Rest of North America
  • Europe Female Fertility and Pregnancy Rapid Test Market
    • By type of test
    • By product
    • By country – U.K., Germany, France, Italy, Spain, and Rest of Europe
  • Asia Female Fertility and Pregnancy Rapid Test Market
    • By type of test
    • By product
    • By country – China, Japan, India, and Rest of Asia
  • Rest of the World (RoW) Female Fertility and Pregnancy Rapid Test Market
    • By type of test
    • By product
    • By country – Brazil, Australia, and Others